Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023		213,481,743
Beginning balance at Dec. 31, 2023	$ 344,029	$ 21	$ 712,307	$ (124)	$ (368,175)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon vesting of RSUs, net of shares withheld for taxes (in shares)		925,243
Payments for taxes related to net share settlement of equity awards	(7,314)		(7,314)
Exercise of vested stock options (in shares)		2,027,347
Exercise of vested stock options	5,070		5,070
Stock-based compensation	19,671		19,671
Other comprehensive income (loss)	(38)			(38)
Repurchase and retirement of common stock (in shares)		(2,023,080)
Repurchases and retirement of common stock	(28,064)		(28,064)
Net income	11,128				11,128
Ending balance (in shares) at Mar. 31, 2024		214,411,253
Ending balance at Mar. 31, 2024	344,482	$ 21	701,670	(162)	(357,047)
Beginning balance (in shares) at Dec. 31, 2024		220,837,209
Beginning balance at Dec. 31, 2024	476,716	$ 22	719,155	(324)	(242,137)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon vesting of RSUs, net of shares withheld for taxes (in shares)		1,179,653
Payments for taxes related to net share settlement of equity awards	(25,711)		(25,711)
Exercise of vested stock options (in shares)		1,274,229
Exercise of vested stock options	3,928		3,928
Issuance of common stock for acquisition of assets (in shares)		292,806
Issuance of common stock for acquisition of assets	12,760		12,760
Common stock to be issued for asset acquisition indemnification holdback	6,380		6,380
Stock-based compensation	25,543		25,543
Other comprehensive income (loss)	160			160
Net income	49,485				49,485
Ending balance (in shares) at Mar. 31, 2025		223,583,897
Ending balance at Mar. 31, 2025	$ 549,261	$ 22	$ 742,055	$ (164)	$ (192,652)